Sale!

Factor V Leiden Mutation Analysis Test

Original price was: 1,430 د.إ.Current price is: 1,290 د.إ.

-10%

The Factor V Leiden Mutation Analysis Test is a specialized diagnostic procedure aimed at detecting the presence of the Factor V Leiden mutation in the DNA. This genetic mutation is associated with an increased risk of developing abnormal blood clots, which can lead to conditions such as deep vein thrombosis (DVT) or pulmonary embolism. The test involves analyzing a sample of the patient’s blood to identify the specific mutation in the Factor V gene that is responsible for the altered function of the clotting factor.

At DNA Labs UAE, this crucial test is offered at a cost of 1290 AED. The laboratory utilizes advanced genetic testing technologies to ensure accurate and reliable results, providing essential information for the assessment of thrombophilia risk. By identifying individuals who carry the Factor V Leiden mutation, healthcare providers can make informed decisions regarding the need for preventive measures or treatment strategies to reduce the risk of thrombotic events. This test is an important tool in the management of patients with a personal or family history of clotting disorders, helping to tailor personalized healthcare plans and improve patient outcomes.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Factor V Leiden Mutation Analysis Test

Test Cost: AED 1290.0

Overview

The Factor V Leiden mutation analysis test is a laboratory test offered by DNA Labs UAE. This test detects the presence of the Factor V Leiden mutation in a person’s DNA. The Factor V Leiden mutation is a genetic mutation that increases the risk of developing abnormal blood clots in veins, a condition known as venous thromboembolism.

Test Components

  • Factor V Leiden Mutation
  • Prothrombin Gene Mutation
  • MTHFR Gene Mutation

Price

AED 1290.0

Sample Condition

3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE.

Report Delivery

SampleMon / Thu by 11 am; Report Wed / Sat

Method

Real Time PCR

Test Type

Thromboembolic disorders

Doctor

Hematologist

Test Department

Molecular Diagnostics

Pre Test Information

No special preparation required

Test Details

The Factor V Leiden mutation analysis test is a laboratory test that detects the presence of the Factor V Leiden mutation in a person’s DNA. The Factor V Leiden mutation is a genetic mutation that increases the risk of developing abnormal blood clots in veins, a condition known as venous thromboembolism. The test is usually performed using a blood sample. The DNA in the blood sample is analyzed to determine if there is a specific mutation in the Factor V gene that is associated with the Factor V Leiden mutation. If the mutation is present, it indicates an increased risk for abnormal blood clotting.

The Factor V Leiden mutation analysis test is often ordered for individuals who have a personal or family history of blood clots, especially if the clots occurred at a young age or without an obvious cause. It may also be ordered for individuals who have recurrent miscarriages or other complications during pregnancy, as the mutation can increase the risk of blood clots during pregnancy.

The results of the test can help healthcare providers determine the appropriate treatment and preventive measures for individuals with the Factor V Leiden mutation. This may include lifestyle changes, such as maintaining a healthy weight and exercising regularly, as well as medication to prevent blood clots.

It is important to note that having the Factor V Leiden mutation does not guarantee that a person will develop blood clots, as other factors, such as lifestyle and other genetic factors, also play a role. Similarly, not having the mutation does not completely eliminate the risk of blood clots, as there are other genetic and environmental factors that can contribute to clotting disorders.

Test Name FACTOR V LEIDEN MUTATION ANALYSIS Test
Components *Factor V Leiden Mutation *Prothrombin Gene Mutation *MTHFR Gene Mutation
Price 1290.0 AED
Sample Condition 3 mL (2 mL min.) whole blood in 1\nLavender Top (EDTA) tube. Ship\nrefrigerated. DO NOT FREEZE.
Report Delivery SampleMon / Thu by 11 am; Report Wed / Sat
Method Real Time PCR
Test type Thromboembolic disorders
Doctor Hematologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information No special preparation required
Test Details

The Factor V Leiden mutation analysis test is a laboratory test that detects the presence of the Factor V Leiden mutation in a person’s DNA. The Factor V Leiden mutation is a genetic mutation that increases the risk of developing abnormal blood clots in veins, a condition known as venous thromboembolism.

The test is usually performed using a blood sample. The DNA in the blood sample is analyzed to determine if there is a specific mutation in the Factor V gene that is associated with the Factor V Leiden mutation. If the mutation is present, it indicates an increased risk for abnormal blood clotting.

The Factor V Leiden mutation analysis test is often ordered for individuals who have a personal or family history of blood clots, especially if the clots occurred at a young age or without an obvious cause. It may also be ordered for individuals who have recurrent miscarriages or other complications during pregnancy, as the mutation can increase the risk of blood clots during pregnancy.

The results of the test can help healthcare providers determine the appropriate treatment and preventive measures for individuals with the Factor V Leiden mutation. This may include lifestyle changes, such as maintaining a healthy weight and exercising regularly, as well as medication to prevent blood clots.

It is important to note that having the Factor V Leiden mutation does not guarantee that a person will develop blood clots, as other factors, such as lifestyle and other genetic factors, also play a role. Similarly, not having the mutation does not completely eliminate the risk of blood clots, as there are other genetic and environmental factors that can contribute to clotting disorders.